A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy have?
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy has 187 citations in the OpenAlex counts ScholarIQ stores.
When was A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy published?
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy has 2019 year in the ScholarIQ index.
What is the open-access status of A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy?
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy has hybrid oa status in the ScholarIQ index.
What is the DOI of A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy?
The DOI for A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy is on the source record.
What is the PMID of A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy?
The PMID for A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy is on the source record.
What is the OpenAlex record for A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy?
The OpenAlex for A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy is on the source record.